Use of home dialysis and modalities other than conventional in-center hemodialysis is expected to grow. Levels of serum markers of chronic kidney disease mineral bone disorders (CKD-MBD) vary across ...

A new review highlights the need to simultaneously control CKD-MBD and MICS in patients receiving hemodialysis. Chronic kidney disease-mineral and bone disorder (CKD-MBD) may promote ...

Denosumab treatment for osteoporosis raises the risk for hypocalcemia, which worsens with advancing stages of chronic kidney disease (CKD), in those with CKD–Mineral and Bone Disorder (CKD-MBD) and in ...

The use of the osteoporosis drug denosumab (Prolia) to prevent fractures associated with advanced chronic kidney disease (CKD) in patients on kidney dialysis significantly increases the risk for ...

Colored x-ray of the pelvic region shows a fractured femur (red) caused by a fall. A lack of clinical trials and limited pharmaceutical options mean that management of this complication poses ...